We are live on
!
Find out more
CSS
Cubist Systematic Strategies Portfolio holdings
AUM
$21B
1-Year Est. Return
21.48%
This Fund
S&P 500
This Quarter
Est. Return
+4.55%
1 Year Est. Return
+21.48%
3 Year Est. Return
+78.34%
5 Year Est. Return
+110.56%
10 Year Est. Return
+239.04%
AUM
$16.4B
AUM Growth
-$748M
(-4.4%)
Cap. Flow
-$1.54B
Cap. Flow
% of AUM
-9.38%
Top 10 Holdings %
Top 10 Hldgs %
4.71%
Holding
4,854
New
668
Increased
1,369
Reduced
1,663
Closed
1,012
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cigna
CI
|
+$82.1M |
| 2 |
Honeywell
HON
|
+$65.3M |
| 3 |
Norfolk Southern
NSC
|
+$60.4M |
| 4 |
SCHW
Charles Schwab
SCHW
|
+$55.7M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$55.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$73.1M |
| 2 |
United Airlines
UAL
|
+$56.6M |
| 3 |
CME Group
CME
|
+$50.4M |
| 4 |
Lam Research
LRCX
|
+$47M |
| 5 |
Southwest Airlines
LUV
|
+$37.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.78% |
| 2 | Financials | 10.54% |
| 3 | Industrials | 9.15% |
| 4 | Healthcare | 9.04% |
| 5 | Consumer Discretionary | 8.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3526
MaxCyte
MXCT
$149M
| $63.1K | ﹤0.01% |
12,750
+12,514
| +5,303% | +$61.6K |
|
3527
AlTi Global
ALTI
$464M
| $63K | ﹤0.01% |
5,023
-26,734
| -84% | -$269K |
|
|
JWN
3528
DELISTED
Nordstrom
JWN
| $62.7K | ﹤0.01% |
3,856
-404,034
| -99% | -$7.55M |
|
|
YELL
3529
DELISTED
Yellow Corporation Common Stock
YELL
| $61.4K | ﹤0.01% |
30,255
-131,332
| -81% | -$350K |
|
|
ETNB
3530
DELISTED
89bio
ETNB
| $61.1K | ﹤0.01% |
4,015
-287,010
| -99% | -$3.74M |
|
3531
Savara
SVRA
$1.08B
| $60.9K | ﹤0.01% |
+31,227
| New | +$70.4K |
|
3532
Tiptree Inc
TIPT
$677M
| $60.7K | ﹤0.01% |
4,165
-3,798
| -48% | -$57.8K |
|
3533
Acumen Pharmaceuticals
ABOS
$184M
| $60.5K | ﹤0.01% |
14,899
-3,093
| -17% | -$16.2K |
|
|
OMGA
3534
DELISTED
Omega Therapeutics, Inc. Common Stock
OMGA
| $60.3K | ﹤0.01% |
10,007
+6,267
| +168% | +$43.6K |
|
3535
Entrada Therapeutics
TRDA
$290M
| $60.3K | ﹤0.01% |
4,160
+3,755
| +927% | +$50.1K |
|
|
SGMO
3536
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $59.6K | ﹤0.01% |
+33,874
| New | +$96.7K |
|
3537
Precigen
PGEN
$2.32B
| $59.5K | ﹤0.01% |
56,110
+21,009
| +60% | +$30.3K |
|
3538
Red Rock Resorts
RRR
$3.67B
| $59.1K | ﹤0.01% |
1,327
-17,126
| -93% | -$758K |
|
|
CVAC
3539
DELISTED
CureVac
CVAC
| $59.1K | ﹤0.01% |
+8,479
| New | +$73.9K |
|
|
EEX
3540
DELISTED
Emerald Holding
EEX
| $59.1K | ﹤0.01% |
+15,883
| New | +$59.4K |
|
3541
Nuvation Bio
NUVB
$2.14B
| $58.8K | ﹤0.01% |
35,446
-9,006
| -20% | -$18.3K |
|
|
IVCPW
3542
DELISTED
Swiftmerge Acquisition Corp. Warrants
IVCPW
| $58.7K | ﹤0.01% |
480,434
| – | – |
|
|
GBIO
3543
DELISTED
Generation Bio
GBIO
| $58.1K | ﹤0.01% |
+1,352
| New | +$65.4K |
|
|
AMRN
3544
Amarin Corp
AMRN
$299M
| $57.9K | ﹤0.01% |
1,931
-8,356
| -81% | -$293K |
|
3545
Nu Holdings
NU
$67.3B
| $57.8K | ﹤0.01% |
12,140
-642,693
| -98% | -$2.86M |
|
3546
VolitionRx Ltd
VNRX
$7.6M
| $57.6K | ﹤0.01% |
+1,509
| New | +$63.1K |
|
3547
Aldeyra Therapeutics
ALDX
$86.9M
| $57.2K | ﹤0.01% |
+5,757
| New | +$40.7K |
|
|
CBIO
3548
Crescent Biopharma
CBIO
$618M
| $56.6K | ﹤0.01% |
449
-34
| -7% | -$7.65K |
|
|
CMRX
3549
DELISTED
Chimerix, Inc.
CMRX
| $56K | ﹤0.01% |
44,467
-19,254
| -30% | -$31.4K |
|
3550
CALL
Nordic American Tanker
NAT
$1.4B
| $55.8K | ﹤0.01% |
+14,100
| New | +$50.6K |
|
Similar funds
GIM
ECM
JFL
BAM
SF
WIM
AIM
SIG
Cubist Systematic Strategies's Q1 2023 Portfolio in Review
As of Q1 2023, Cubist Systematic Strategies held 4,854 positions worth $16.4B, down 4.4% from $17.1B the previous quarter. Its ten largest holdings account for 4.7% of the portfolio.
Cubist Systematic Strategies withdrew a net $1.54B in Q1 2023, closing 1,012 positions and reducing 1,663 holdings. Its most notable exit was Graco, an estimated $21.6M position sold in full.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 12% a quarter earlier, followed by Financials and Industrials.
Against the trend, Cubist Systematic Strategies opened a new position in Coterra Energy worth $14.3M.
- Cubist Systematic Strategies's largest Q1 2023 buy was Coterra Energy: 582,419 shares worth $14.3M.
- Cubist Systematic Strategies added most to Cigna in Q1 2023, an estimated $82.1M increase.
- Cubist Systematic Strategies's biggest Q1 2023 reduction was Apple, cutting an estimated $73.1M.
- Cubist Systematic Strategies fully exited Graco in Q1 2023, selling an estimated $21.6M.
- Cubist Systematic Strategies's ten largest holdings make up 4.7% of its $16.4B portfolio in Q1 2023.
- Cubist Systematic Strategies opened 668 new positions and closed 1,012 in Q1 2023.
- Cubist Systematic Strategies's portfolio value fell 4.4% quarter-over-quarter to $16.4B.
Based on Cubist Systematic Strategies's 13F filing for Q1 2023, filed 15 May 2023.